Literature DB >> 849810

Use of dexamethasone in treatment of insulin lipoatrophy.

O Kumar, L Miller, S Mehtalia.   

Abstract

To treat insulin lipoatrophy, small amounts of dexamethasone (4 micrograms/unit) were added to insulin injections in nine patients. Six cases showed significant improvement of dexamethasone-treated sites over that of control sites in six months. With the continued use of dexamethasone-containing insulin, they remained mostly free of atrophic areas during the follow-up period of over two years. Our experience suggests the usefulness of this therapy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 849810     DOI: 10.2337/diab.26.4.296

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  6 in total

1.  Continuous subcutaneous insulin infusion (CSII) in the management of diabetic lipodystrophy: a case report.

Authors:  A Cimino; U Valentini; A Rotondi; E Radaeli; G Giustina
Journal:  Acta Diabetol Lat       Date:  1987 Apr-Jun

Review 2.  The new insulins. Their characteristics and clinical indications.

Authors:  P D Home; K G Alberti
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546

3.  Insulin-induced lipoatrophy: evidence for an immune pathogenesis.

Authors:  W G Reeves; B R Allen; R B Tattersall
Journal:  Br Med J       Date:  1980-06-21

4.  Relapsing insulin-induced lipoatrophy, cured by prolonged low-dose oral prednisone: a case report.

Authors:  Ernst A Chantelau; Ruth Praetor; Jörg Praetor; Ludger W Poll
Journal:  Diabetol Metab Syndr       Date:  2011-12-06       Impact factor: 3.320

5.  Prevalence, Risk Factors, and Clinical Characteristics of Lipodystrophy in Insulin-Treated Patients with Diabetes: An Old Problem in a New Era of Modern Insulin.

Authors:  Yotsapon Thewjitcharoen; Hussamon Prasartkaew; Phatharaporn Tongsumrit; Saruda Wongjom; Chatnapa Boonchoo; Siriwan Butadej; Soontaree Nakasatien; Krittadhee Karndumri; Veekij Veerasomboonsin; Sirinate Krittiyawong; Thep Himathongkam
Journal:  Diabetes Metab Syndr Obes       Date:  2020-11-26       Impact factor: 3.168

6.  Concurrence of Lipoatrophy and Lipohypertrophy in Children With Type 1 Diabetes Using Recombinant Human Insulin: Two Case Reports.

Authors:  Arijit Singha; Rana Bhattarcharjee; Sujoy Ghosh; Sumit Kumar Chakrabarti; Arjun Baidya; Subhankar Chowdhury
Journal:  Clin Diabetes       Date:  2016-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.